Delivery Order SPE2DB25D3504-SPE2DB25FVUCP

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,164.42, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and the ultimate completion date...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $5,586.93, is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,272.60 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $5,930.79. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 16, 2023. This award is not associated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.23, is for the delivery of Atovaquone-Proguanil 250-100 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,690.26 for the procurement of ATOVAQUONE-PROGUANIL 250-100 100S, which are medical commodities used in healthcare. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there...
This federal contract award is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,651.17, is for the procurement of 4563736195 ATOVAQUONE-PROGUANIL 250-100 UD 24S, a medical product. The delivery order has an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,787.40 firm fixed-price delivery order is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract has a period of performance through March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product, with a ceiling value of $5,393.79. The contract is a firm-fixed price delivery order, with a period of performance ending on May 29, 2025. The contract is not set aside and was awarded on May 28, 2025. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ATOVAQUONE-PROGUANIL 250-100 100S pharmaceutical products. The award, valued at $7,756.47, has an ultimate completion date of August 14, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides for the delivery of a comprehensive range of medical...
  • SPE2DB25D3504
    Indefinite Delivery Contract
  • SPE2DB25D3504-SPE2DB25FVUCP
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,647.47, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is April 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/4/25, 11:34 AM